News
J&J says two drugs are better than one in pretreated myeloma
Combining Johnson & Johnson's multiple myeloma therapies Talvey and Tecvayli shows promise in a hard-to-treat form of multiple myeloma.
Oncology
Treating primary bone cancer: The potential of listeria-base...
In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Oncology
Beyond traditional cancer treatment: Can we confront unmet n...
Surgery, chemotherapy, radiotherapy, and immunotherapy are designed to kill cancer, but what if we could control cancer?
News
NHS starts first national rollout of Blenrep for myeloma
England is the first country in the world to make GSK's relaunched anti-BCMA drug Blenrep available to patients with multiple myeloma.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
